Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
Zhu, Meng-Xuan, Wei, Chuan-Yuan, Zhang, Peng-Fei, Gao, Dong-Mei, Chen, Jie, Zhao, Yan, Dong, Shuang-Shuang, Liu, Bin-BinТом:
38
Мова:
english
Журнал:
Journal of Experimental & Clinical Cancer Research
DOI:
10.1186/s13046-019-1401-y
Date:
December, 2019
Файл:
PDF, 4.48 MB
english, 2019
File converter
Більше результатів пошуку
More benefits 
